<DOC>
	<DOCNO>NCT01219686</DOCNO>
	<brief_summary>The main purpose study determine whether antidepressant response escitalopram 30mg/day escitalopram 20mg/day + pindolol , beta blocker , different ( faster ) compare standard dose escitalopram 20mg/day .</brief_summary>
	<brief_title>EScitalopram PIndolol ONset Action</brief_title>
	<detailed_description>Antidepressant drug therapy primary therapeutic treatment option moderate severe Major Depressive Disorder . However , clinically significant antidepressant response need sustain treatment week month . Indeed , large effectiveness study conduct date ( STAR*D study ) involve nearly 3000 depressed outpatient , one third ultimately respond 6 week drug treatment patient longer treatment period necessary . This delay imply prolonged suffering patient family . By antagonist action serotonin 1A receptor pindolol hypothesize reduce down-regulation mechanism antidepressant . It therefore expect addition pindolol escitalopram shorten therapeutic response . Clinical preclinical data indicate escitalopram 30 mg/day might effective perhaps associate faster onset action 20mg . For purpose speed action compare three blindly randomize sample : - escitalopram 20mg per day + placebo - escitalopram 30mg per day + placebo - escitalopram 20mg per day + pindolol 15mg per day ( two dose 7.5mg 14 day ) . Subjects follow 6 week . The dose 15mg pindolol per day ( 14 day ) base optimal occupancy serotonin 1A receptor . At inclusion subject assess trained psychiatrist use SCID I mood disorder part base DSM IV criterion , mean French version MINI . Severity depression assess use MADRS clinician rat self-report questionnaire , French version QIDS . Each week subject assess use two version Montgomery-Asberg Depression Rating Scale ( MADRS ) HCL-32 self-report questionnaire assess hypomania . It plan include 135 patient three year study duration result 45 subject group .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Pindolol</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>patient age 18 65 year old patient suffer major depression accord DSMIV MADRS score least 25 treated antidepressant time inclusion exception nonresponders antidepressant period least 6 week tolerate ongoing antidepressant necessitating change antidepressant ( exclude fluoxetine irreversible MAOI ) inform consent Exclusion criterion : Axis I disorder exclude anxiety disorder dominate clinical picture , nicotine abuse nonresponders escitalopram past already take pindolol pregnancy breast feed contraindication one two treatment ( medical condition , drug treatment ) significant somatic comorbidity interfere study procedure high risk suicidality woman childbearing age safe mean contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>unipolar depression , escitalopram , pindolol</keyword>
</DOC>